One to 4 days before birth of their litters, pregnant buffalo rats were injected intravenously with 200 p C i of [2-I4C]glycine in order to label a cohort of fetally produced red blood cells (RBC). Shortly after birth, the newborn rats were transferred to noninjected foster mothers, and R B C survival was determined by the rate of production of 14C0 in the expired air of the newborn animals. In separate experiments, pregnant rats were injected 1-2 days before birth of their litters; blood was collected from the newborn a t 5 days of age, washed, transfused into normal adult hosts, and R B C survival determined from the resultant I4CO production. When compared with adult RBC, in situ survival of fetallv produced R B C was 2 2 % of normal (mean suggested for fetal R B C by following the rate of fall of fetal hemoglobin levels in fully compatible mothers autotransfused during the prenatal period (4, 15) .
Summary
One to 4 days before birth of their litters, pregnant buffalo rats were injected intravenously with 200 p C i of [2-I4C] glycine in order to label a cohort of fetally produced red blood cells (RBC). Shortly after birth, the newborn rats were transferred to noninjected foster mothers, and R B C survival was determined by the rate of production of 14C0 in the expired air of the newborn animals. In separate experiments, pregnant rats were injected 1-2 days before birth of their litters; blood was collected from the newborn a t 5 days of age, washed, transfused into normal adult hosts, and R B C survival determined from the resultant I4CO production. When compared with adult RBC, in situ survival of fetallv produced R B C was 2 2 % of normal (mean suggested for fetal R B C by following the rate of fall of fetal hemoglobin levels in fully compatible mothers autotransfused during the prenatal period (4, 15) .
Recent studies of R B C destruction in the newborn dog (12) suggest a rapid elimination of fetally produced R B C during the immediate postnatal period. Since R B C survival is shorter in the premature infant than in the full term, and appears to decrease with decreasing birth weight (7) . it has been concluded that R B C produced before birth have a markedly shortened survival, whereas those produced after birth have either slightly shortened or normal survival (2) . The present study was undertaken in order to test this assumption by following the in situ survival of R B C produced in utero, using a noneluting cohort technique.
life span of 12.1 d a i s i n the fetus, and 54.5 + 1.5 (SE) days in MATERIALS A N D METHODS the adult). This shortening of survival resulted from a n acceleration of R B C senescence (15.7 days for fetal R B C and 66.2 & 0.7 A11 studies were performed in specific pathogen-free highly days for adult RBC) and a n increased rate of random hemolysis inbred buffalo rats (Simonsen Laboratories, Gilroy, Calif.). (3.70%/day in the fetal R B C and 0.67 & 0.07%/day in adult Pregnant rats were injected intravenously with 200 p C i of . Although cross-transfusion of adult R B C into compatible '4C]glycine (New England Nuclear, Boston, Mass.) under light adult rat hosts resulted in only a modest shortening of R B C ether anesthesia 24-96 hr before birth of their litters. Timing of 1 lifespan (mean R B C survival reduced from 54.5 + 1.5 days to these injections was facilitated by knowledge of the time of 52.8 + 0.8 days), similar treatment of fetally produced R B C appearance of a vaginal postcoital plug. However, the variation resulted in a marked acceleration of senescence from 15.7 days in delivery times for animals with similar appearance times of t o 5.8 days. Examination of the R B C survival curves for those vaginal plugs indicated that frequent abdominal palpation and litters injected less than 7 2 hr before birth indicated the presence inspection was a more reliable indicator of impending delivery. of an additional population of cells with survival in the range of After birth of the litters, the radioactive mothers were re-25-40 days. The proportion of cells surviving longer than the placed by noninjected female rats which had also delivered major cohort (but shorter than times characteristic of adult litters within the preceding 24 hr. After a short period of adapta-RBC) increased as the time interval between isotope injection tion in a darkened quiet area, the suckling radioactive litters and and birth decreased.
the nonradioactive foster mothers were studied as a group in the metabolism chamber system (see below). A11 such litters were Speculation accepted by the foster mothers and gained weight normally, without loss of animals from cannibalism. The magnitude of the shortening in survival noted for fetal For the study of R B C lifespan, the foster mother and litter R B C suggests the presence of structural and/or metabolic altera-were placed as a group in a darkened metabolism chamber tions peculiar to these cells, rather than alterations secondary t o containing bedding, food, and water. Air exiting from the chamincreased erythropoietic rate alone.
ber was assayed for "CO by methods previously described (1 1). and was calculated in terms of disintegrations per min. hr. Red blood cell survival was calculated by computer analysis of the Numerous studies have shown shortened survival for R B C of curves of I4CO production versus time after isotope injection full term and premature infants. For cord R B C of premature (10, 11) . In this glycine-CO method, isotope is incorporated into infants, "Cr half-times in adult hosts average 16-17 days, as heme, and is metabolically converted to I4CO when such heme is compared with values of 18-27 days for cord RBC of full term degraded in vivo. The IJCO thus formed, representing mole for infants, and 24-32 days for adult R B C (14, 17) . Full interpreta-mole the destruction of labeled heme, is excreted intact in the tion of this 51Cr data is complicated by the lack of steady state breath. Prior studies in adult and newborn rats have shown that conditions in such newborns, their young RBC population, and I4CO arising from degradation of nonhemoglobin heme and possible variations in the rate of label elution. However, cohort ineffective erythropoiesis (the "early labeled peak") appears labeling with 59Fe (5) and ['Wklycine (16) confirmed the re-almost exclusively during the first 2-3 days after isotope injecduced survival of such cells. Similar shortening of survival was tion (9-11). The production of 14C0 more than 3 days after isotope injection thus represents the instantaneous destruction of circulating RBC, and can be used to determine erythrocyte survival (10, 11) . This method avoids blood sampling, and is independent of alterations in blood volume, since it measures total labeled heme degradation. A s a cohort technique, it also avoids the problems inherent in and [32P]difluorophosphate methods in which cells of all ages are labeled, and in which variable label elution may occur.
For cross-transfusion studies, three pregnant rats were injected intravenously with 200 pCi each of [2-14C]glycine before birth of their litters. When the litters were 5 days old, blood was collected by decapitation and bleeding into vials of cold Hanks' buffered saline solution. The blood obtained from each litter was washed three times in cold Hanks' solution, diluted to a total of 2.5 ml, and injected intravenously into each of three adult male buffalo rats. Survival of the RBC in these cross-transfused animals was calculated as for the in situ studies.
T o facilitate graphic and mathematical analyses, curves of ' T O production rate versus time after isotope injection were normalized for each litter, such that "CO production was 100 dpmlhr 15-16 days after isotope injection. The available data was then pooled, with each data point representing the mean of l 4 C0 EXCRETION RATE ( D P M / HOUR normalized ' T O production from at least five of the eight available litters (Fig. 1 ) or for at least three of the four available litters (Fig. 2) . Figure 1 indicates ' T O production as a function of time after isotope injection for the 8 litters injected in lrrero, as well as for three normal adult male rats of the same strain (11) . For the adult animals, peak ' T O production at 65 days after isotope injection represents death by senescence of the RBC cohort. For the studies in which labeled glycine was injected in utero, the curve for ' T O production is markedly shifted and skewed, indicating a shortened mean potential lifespan (acceleration of senescence) and increased random destruction. Computer evaluation of this data (1 1) indicated that the mean overall lifespan of RBC produced it1 urero is 12 days, or about 22% of that seen in the adult rat (Table 1 ). For the four litters injected 24-36 hr before birth, the ' T O excretion curve showed a secondary rise at about 25-35 days (Fig. 2, 0) . In contrast, the four litters injected 48-96 hours before birth had I4CO excretion curves characteristic of a single cohort of RBC (Fig. 2, e) . The Best fit parameters for these curves are shown in Table 1 . hr before birth was 7.5-1 1.5 % of maximal ("peak") values, in good agreement with the value of 8% expected from a single cohort of R B C having survival parameters as shown in Table 1 (first column). The magnitude of this additional ' T O increased progressively as the time interval between isotope injection and birth decreased (Fig. 3) . Figure 4 , and is compared with a survival curve obtained following cross-transfusion of adult buffalo rat RBC into separate adult buffalo rat hosts. For the latter, RBC lifespan is similar to that noted for the in sirii studies, with a mean time of senescent RBC death of 65 days. For RBC labeled it1 irtero 24-48 hr before birth, and transfused into adults on the 5th day of life, the ' T O The solid line represents the computer-derived best fit as shown in Figure 1 . Note the presence of a secondary rise in ' T O excretion only for those red blood cell cohorts labeled 24-36 hr before birth. data indicates a mean time of senescent death of not more than 6 days (approximately 12% of normal). There was no evidence for ' T O production during the times characteristic of the death of adult RBC. However, when the computer-generated best fit (-, Fig. 4) is compared with the actual data ( 0 , Fig. 4) , it can be seen that I4CO production is greater than predicted during the time period 25-45 days postinjection, suggesting the production in the fetus of a small population of RBC with a lifetime longer than 20 days, but less than that characteristic of adult RBC. Computer analysis of this data (Table 1) Figure I ; best fit parameters for these two curves are given in Table 1. adult host compromises the survival of these cells to a greater extent than does similar handling of adult RBC. Whereas crosstransfusion of adult RBC results in less than 5 % shortening of survival (1 1). similar treatment of fetally labeled RBC resulted in an acceleration of senescence from 16 days to less than 6 days, or a shortening in survival of at least 60%. DISCUSSION These studies indicate that survival of RBC produced in irtero in the rat is approximately 22% of that noted in adult rats because of accelerated senescence (24% of normal) and increased random hemolysis (5.5 times normal). That this altered survival is due to a defect intrinsic to the fetal RBC is indicated by the shortened survival of these cells when transfused into compatible adult rats.
RESULTS

The ' T O data for the cross-transfusion studies is shown in
I 4 c 0 EXCRETION RATE (DPM/HR) DAYS AFTER GLYCINE-2-14c INJECTION
When data from individual litters was analyzed separately, it was noted that litters born within 24-36 hr of injection of labeled glycine had evidence for an additional population of RBC with a lifespan in the range of 30 days (Fig. 2) . For animals injected 72 hr or more before birth, "CO production 30-40 days after isotope injection was equal to that expected from destruction of a single cohort. For those injected less than 72 hr before birth, this additional ' T O production increased progressively as the time interval between isotope injection and birth decreased (Fig.  3) . Similar behavior can be seen for the cross-transfused RBC, since these were obtained from litters injected 24-48 hr before birth (Fig. 4) . Since in all cases maximal RBC destruction was found at 14-16 days after isotope injection, these data can be interpreted to mean that there is the appearance of a second cohort of RBC living longer than the mean, and that the size of this additional RBC population increases progressively with advancing fetal age. A similarly skewed survival was predicted for the human newborn by Bratteby et al. (3) . although these authors noted that their derived lifespan frequency function did not change appreciably during the last 60 days of fetal life.
Recent experiments (8) indicate that the survival of cohorts of RBC produced in 2-day-old rats is approximately twice that noted for fetal RBC (55% of normal), whereas that for RBC formed in 5-10-day-old rats was approximately 75% of normal. Cross-transfusion studies of the latter RBC into adult hosts confirmed the longer survival as well as the intrinsic nature of the RBC defect. It can be concluded that survival of RBC is continuously improving during the last 96 hr of fetal development in the rat, and rapidly improves towards normal following birth. These alterations in survival correlate with the progressive increase in body weight of the newborn rats, in agreement with observations by Kaplan and Hsu (7) for newborn man, as well as with the generally noted increase in RBC survival as a function of increasing body weight in the animal kingdom (1) . Indeed, these studies document the shortest RBC survival for any normal mammalian species reported to date.
The marked degree of shortening of survival after cross-transfusion of fetal RBC suggests that these cells are more sensitive to in vitro manipulation than are comparably handled adult RBC RBC. However, it is also possible that reticuloendothelial hypofunction in such fetal animals (6) may prolong the observed in siru survival, and that cross-transfusion into adults with normally functioning spleens uncovers the true magnitude of the RBC defect.
Previous studies in adult buffalo rats have confirmed the presence of accelerated RBC senescence with increasing erythropoietic rate (9) . However, increases in erythropoietic rate up to 10 times normal following phlebotomy or phenylhdrazine treatment resulted in an acceleration of RBC senescence of not more than 20-35%. This is of sufficient magnitude to explain the survival of RBC formed in 5-10-day-old rats, but is insufficient to explain the 76-91 % acceleration of senescence noted for fetal RBC in this study. Therefore, one is tempted to conclude that the marked alterations in survival of fetal RBC primarily reflect metabolic and/or structural differences peculiar to fetal RBC (13) , rather than alterations secondary to an increased erythropoietic rate (2, 14) . CONCLUSION The survival of fetal RBC in the rat was studied by a cohort technique, employing the production of 14C0 in newborn litters following injection of labeled glycine into pregnant rats. Noninjected foster mothers replaced the originally injected mothers so that the only source of ' T O would be from the degradation of heme labeled it1 utero. In eight litters injected 24-96 hr before birth, RBC senescence was noted to be markedly accelerated, and random hemolysis was increased, resulting in a mean overall RBC survival 22% of normal. Cross-transfusion of RBC labeled it1 Ictero into adult hosts confirmed the intrinsic nature of the defect in these cells. These studies appear to be the first direct testing of the survival of fetally produced RBC in an animal species, and confirm the general suspicion that the survival of such cells is markedly reduced.
